How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C
Open Access
- 6 May 2021
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (7) , e29049
Abstract
Thrombosis within the microvasculature and medium to large vessels is a serious and common complication among critically ill individuals with coronavirus disease 2019 (COVID‐19). While children are markedly less likely to develop severe disease than adults, they remain at risk for thrombosis during acute infection and with the post‐acute inflammatory illness termed multisystem inflammatory syndrome in children. Significant knowledge deficits in understanding COVID‐19‐associated coagulopathy and thrombotic risk pose clinical challenges for pediatric providers who must incorporate expert opinion and personal experience to manage individual patients. We discuss clinical scenarios to provide framework for characterizing thrombosis risk and thromboprophylaxis in children with COVID‐19.Keywords
This publication has 76 references indexed in Scilit:
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysisThrombosis Research, 2019
- Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database studyBlood Advances, 2018
- TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialBMC Pediatrics, 2017
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Venous Thromboembolism in Children with Cancer and Blood DisordersFrontiers in Pediatrics, 2017
- Venous thromboembolism incidence in the Cooperative Study of Sickle Cell DiseaseJournal of Thrombosis and Haemostasis, 2014
- Epidemiology of venous thrombosis in children with cancerThrombosis and Haemostasis, 2014
- Tapered oral dexamethasone for the acute chest syndrome of sickle cell diseaseBritish Journal of Haematology, 2011
- Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide studyGut, 2011
- Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell diseasePediatric Blood & Cancer, 2007